# First-in-Human Study of ADCE-B05 in Patients With Advanced Solid Tumors

> **NCT07362888** · PHASE1 · RECRUITING · sponsor: **Adcendo ApS** · enrollment: 180 (estimated)

## Conditions studied

- Solid Tumors (Phase 1)

## Interventions

- **DRUG:** ADCE-B05

## Key facts

- **NCT ID:** NCT07362888
- **Lead sponsor:** Adcendo ApS
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-03-17
- **Primary completion:** 2026-12-31
- **Final completion:** 2029-03-14
- **Target enrollment:** 180 (ESTIMATED)
- **Last updated:** 2026-04-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07362888

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07362888, "First-in-Human Study of ADCE-B05 in Patients With Advanced Solid Tumors". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT07362888. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*